We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Deep Learning–Based Method Improves Cancer Diagnosis

By LabMedica International staff writers
Posted on 12 Jan 2026

Identifying vascular invasion is critical for determining how aggressive a cancer is, yet doing so reliably can be difficult using standard pathology workflows. More...

Conventional methods require multiple chemical stains to be applied to separate tissue sections, which increases cost, processing time, and the risk of losing diagnostic information. Researchers have now developed an artificial intelligence (AI)-based approach that can digitally generate multiple diagnostic stains from a single unstained tissue section, enabling more accurate assessment of cancer invasion.

Researchers at the University of California, Los Angeles (UCLA, Los Angeles, CA, USA), in collaboration with Hadassah Hebrew University Medical Center (Jerusalem, Israel) and the University of Southern California (USC, Los Angeles, CA, USA), have introduced a virtual multiplexed immunohistochemistry framework that converts autofluorescence microscopy images of label-free tissue into brightfield-equivalent images of hematoxylin and eosin staining, along with two key immunohistochemical markers: ERG for endothelial cells and PanCK for epithelial tumor cells.

Unstained tissue sections were first imaged using autofluorescence microscopy. A conditional generative adversarial network then digitally transformed these images into multiple virtual stains using a single deep neural network. A digital staining matrix guided the model to produce precisely aligned virtual H&E, ERG, and PanCK images from the same tissue section, eliminating the need for serial sectioning and chemical staining.

When applied to thyroid tissue microarrays, the virtual staining approach showed high concordance with conventional histochemical and immunohistochemical stains. In blinded evaluations, board-certified pathologists found that the digitally generated stains were comparable to traditional methods and, in some cases, demonstrated improved consistency and specificity. The approach, presented in BME Frontiers, enabled clearer visualization of tumor cells within blood or lymphatic vessels, supporting more reliable identification of vascular invasion.

Because the staining is generated computationally, the method avoids many artifacts associated with conventional immunohistochemistry and delivers highly reproducible results. Virtual stains can be produced within seconds for individual regions and in minutes for whole-slide images, making the framework compatible with high-throughput digital pathology workflows. While demonstrated in thyroid cancer, the approach could be extended to other tumor types and additional diagnostic markers, pending further multi-center clinical validation.

Related Links:
UCLA
Hadassah Hebrew University Medical Center
USC


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
New
Silver Member
Connectivity Solution
EKF Link
Gold Member
Electrolyte Analyzer
CBS-4000 (CBS-400)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The test combines RNA signals from the tumor-immune microenvironment to predict treatment response, rather than relying on a single marker such as PD-L1 expression.(Image Credit: Adobe Stock)

RNA-Based Test Predicts Immunotherapy Response in Non-Small Cell Lung Cancer

Non-small cell lung cancer (NSCLC) represents the largest U.S. patient population eligible for immune checkpoint inhibitor therapy. Treatment selection often relies on PD-L1 expression, but a single protein... Read more

Immunology

view channel
Image Credit: Adobe Stock

Immune Profiling Identifies Early Maternal Autoantibodies Linked to Preterm Birth Risk

A typical pregnancy lasts about 40 weeks, but labor begins prematurely in roughly one in 10 pregnancies. Preterm birth is the leading cause of newborn death worldwide, yet its underlying causes and which... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image Credit: iStock

Global TB Summit Connects Diagnostic Testing With Prevention and Clinical Care

Tuberculosis remains a major global infectious disease challenge despite declining deaths. In 2024, an estimated 10.7 million people worldwide developed the disease and nearly 1.2 million died from it.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.